Subtype
Malignant Anorectal Neoplasm
CI-CAN-00005864Explore in graph →
452 active trials1 approved drugs6 evidence items
- NCIt
- C215225
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005864Explore in graph →
Clinical trials
1,783 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (174)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02280070 | RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). | unknown | Phase 2 | 110 | Clinical Research Support Center KyushOTHER | 1 | Oct 31, 2014 | clinicaltrials |
| NCT01941979 | A Study Comparing Adjuvant Chemotherapy Versus Observation for Patients With Rectal Adenocarcinoma After Neoadjuvant Chemo-Radiotherapy Treatment. | unknown | Phase 3 | 309 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Oct 30, 2014 |
| clinicaltrials |
| NCT02268006 | IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment(BISER) | unknown | Phase 2 | 50 | Institute of Oncology LjubljanaOTHER | 1 | Oct 20, 2014 | clinicaltrials |
| NCT01801059 | Patient Activation Intervention in Improving Screening Rates for Colorectal Cancer | completed | N/A | 284 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Oct 16, 2014 | clinicaltrials |
| NCT00066430 | Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia | completed | Phase 1 | 18 | AIDS Malignancy ConsortiumNETWORK | 1 | Sep 17, 2014 | clinicaltrials |
| NCT00433576 | Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Sep 15, 2014 | clinicaltrials |
| NCT01525056 | Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI | completed | Phase 2 | 30 | London Health Sciences CentreOTHER | 1 | Sep 9, 2014 | clinicaltrials |
| NCT01365910 | Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer | terminated | Phase 2 | 30 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 26, 2014 | clinicaltrials |
| NCT01105377 | Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 47 | National Cancer Institute (NCI)NIH | 1 | Aug 1, 2014 | clinicaltrials |
| NCT00499369 | Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy | terminated | Phase 3 | 72 | National Cancer Institute (NCI)NIH | 1 | Jul 31, 2014 | clinicaltrials |
| NCT01198548 | High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer | terminated | Phase 2 | 10 | Roswell Park Cancer InstituteOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT01941173 | Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT02188927 | Effect of an Advanced Notification Letter on Screening Colonoscopy Participation | unknown | N/A | 6,800 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Jul 14, 2014 | clinicaltrials |
| NCT02177084 | Percutaneous Tibial Nerve Stimulation in the Treatment of Anterior Resection Syndrome After Rectal Cancer Surgery | unknown | Phase 2 | 12 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jun 27, 2014 | clinicaltrials |
| NCT00942266 | Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment | completed | Phase 2 | 58 | Roswell Park Cancer InstituteOTHER | 1 | Jun 23, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT01217450 | Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | May 29, 2014 | clinicaltrials |
| NCT00835679 | Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery | terminated | Early Phase 1 | 9 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT01116687 | RO4929097 in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00504153 | Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | May 19, 2014 | clinicaltrials |
| NCT01859442 | The Effect of Cancer Therapies and Exercise on Mitochondrial Energetics and Fitness | completed | Early Phase 1 | 12 | Michelle MossaOTHER_GOV | 1 | May 6, 2014 | clinicaltrials |
| NCT01835925 | Rectal Cancer Consortium | completed | — | 12 | Brown UniversityOTHER | 1 | May 1, 2014 | clinicaltrials |
| NCT00625651 | Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 202 | AmgenINDUSTRY | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00134069 | Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01325909 | Exercise Training in Colorectal Cancer Patients | completed | N/A | 35 | Michelle MossaOTHER_GOV | 1 | Apr 7, 2014 | clinicaltrials |
| NCT01233505 | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 16 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00088933 | Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 31, 2014 | clinicaltrials |
| NCT01941966 | A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal. | completed | Phase 2 | 51 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Mar 28, 2014 | clinicaltrials |
| NCT01434147 | Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy | completed | Phase 2 | 25 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Mar 7, 2014 | clinicaltrials |
| NCT02081547 | IPC Status as a Surgical Quality Marker in Rectal Cancer Surgery | unknown | — | 50 | Uppsala UniversityOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00630786 | Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study | completed | Phase 1 / Phase 2 | 53 | AmgenINDUSTRY | 0 | Feb 6, 2014 | clinicaltrials |
| NCT01706809 | Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum Cancer | unknown | — | 30 | Odense University HospitalOTHER | 1 | Feb 5, 2014 | clinicaltrials |
| NCT01865071 | Early Closure of Temporary Loop Ileostomy After Rectal Resection for Cancer | unknown | N/A | 150 | Odense University HospitalOTHER | 1 | Feb 5, 2014 | clinicaltrials |
| NCT01755585 | Irradiation Modulates the Pharmacokinetics of Anticancer Drugs | unknown | — | 40 | Far Eastern Memorial HospitalOTHER | 0 | Jan 22, 2014 | clinicaltrials |
| NCT01403103 | Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer | withdrawn | Early Phase 1 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Jan 17, 2014 | clinicaltrials |
| NCT00795301 | A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab | unknown | Phase 2 | 74 | National University Hospital, SingaporeOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT02036112 | Conventional Versus Individual Extralvator Abdominoperineal Excision for Advanced Lower Rectal Cancer(ELAPE) | unknown | N/A | 60 | Beijing Chao Yang HospitalOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00297141 | Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma | completed | Phase 2 | 60 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Dec 31, 2013 | clinicaltrials |
| NCT02022852 | Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer | unknown | Phase 2 | 80 | Harbin Medical UniversityOTHER | 1 | Dec 30, 2013 | clinicaltrials |
| NCT00701012 | Comparison of Low and High Ligation in the Rectal Cancer | completed | N/A | 100 | Wakayama Medical UniversityOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT01741636 | Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer | completed | N/A | 30 | City of Hope Medical CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00949273 | Safety and Efficacy Study of Cylindrical Abdominoperineal Resection to Treat Rectal Cancer | unknown | — | 300 | Beijing Chao Yang HospitalOTHER | 1 | Nov 28, 2013 | clinicaltrials |
| NCT00973440 | Computer-Based Comprehensive Geriatric Assessment in Oncology for Individuals 70 or Older With Gastrointestinal Malignancies | completed | — | 59 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 22, 2013 | clinicaltrials |
| NCT00909987 | Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum | completed | Phase 2 | 46 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Oct 11, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00060411 | A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00138177 | Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01582750 | Endoscopic Ultrasound Predict the Sensitivity of Stage II / III Rectal Cancer Preoperative Concurrent Chemoradiotherapy | unknown | — | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 19, 2013 | clinicaltrials |
| NCT01790230 | LifeSeal™ Preliminary Study in Subjects Undergoing Low Anterior Resection | completed | N/A | 10 | LifeBond Ltd.INDUSTRY | 1 | Sep 4, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Oct 31, 2014source: clinicaltrials